Invention Grant
- Patent Title: Assessment of coronary heart disease with carbon dioxide
-
Application No.: US17463073Application Date: 2021-08-31
-
Publication No.: US12076421B2Publication Date: 2024-09-03
- Inventor: Rohan Dharmakumar , Debiao Li , Sotirios A. Tsaftaris
- Applicant: Cedars-Sinai Medical Center
- Applicant Address: US CA Los Angeles
- Assignee: Cedars-Sinai Medical Center
- Current Assignee: Cedars-Sinai Medical Center
- Current Assignee Address: US CA Los Angeles
- Agency: NIXON PEABODY LLP
- Main IPC: A61K49/08
- IPC: A61K49/08 ; A61K31/7076 ; A61K33/00

Abstract:
There are provided methods for diagnosing coronary heart disease in a subject in need thereof comprising administering an admixture comprising CO2 to a subject to reach a predetermined PaCO2 in the subject to induce hyperemia, monitoring vascular reactivity in the subject and diagnosing the presence or absence of coronary heart disease in the subject, wherein decreased vascular reactivity in the subject compared to a control subject is indicative of coronary heart disease. There are also provided methods for increasing sensitivity and specificity of BOLD MRI.
Public/Granted literature
- US20220054661A1 ASSESSMENT OF CORONARY HEART DISEASE WITH CARBON DIOXIDE Public/Granted day:2022-02-24
Information query